期刊文献+

PCL-PEG-PCL载姜黄素纳米粒子的制备以及体外药物释放的考察 被引量:13

Curcumin Loaded PCL-PEG-PCL Nanoparticle: Preparation,Characterization and in Vitro Release Study
原文传递
导出
摘要 目的制备一种生物可降解、生物相容性良好的姜黄素纳米粒子,并对其体外药物释放行为进行考察。方法采用开环聚合法制备生物可降解的PCL-PEG-PCL三嵌段聚合物,然后采用乳液挥发法制备负载姜黄素的PCL-PEG-PCL纳米粒子,通过透射电镜观察所制备纳米粒子的形貌特征,动态光散射(DLS)测定粒径,采用HPLC测定纳米粒子的包封率和载药量,同时考察其体外药物释放行为。结果姜黄素纳米粒子具有球形结构,粒径在200 nm左右,载药量为(14.23±0.35)%,3 d体外累积释药量65%。结论所制备的姜黄素纳米粒子具有较高的载药量和包封率,同时体外药物释放实验证实姜黄素纳米粒子具有良好的缓释功能。 OBJECTIVE To develop a novel biodegradable, biocompatible curcumin loaded PCEC (PCL-PEG-PCL) nanoparticles for potential application in the drug delivery system. METHODS PCEC copolymer was synthesized by the ring-opening polymerization method and its nanoparticles (blank and curcumin loaded PCEC nanoparticles) were prepared by the emulsification-evaporation method. The developed curcumin loaded PCEC nanoparticles were characterized by scanning electron microscopy (SEM), dynamic light scattering (DLS) and etc. Drug loading capacity/efficiency was determined by HPLC. In vitro release behavior of curcumin from nanoparticles was also investigated. RESULTS The developed curcumin loaded PCEC nanoparticle showed almost spherical in shape with uniform mean particle size about 200 nm. The drug loading capacity of curcumin was appromimately (14.23~0.35)%. In vitro release study showed that 65% of total curcurnin was released from nanoparticle after 3 days. CONCLUSION The developed PCEC nanopartiele is an excellent carrier for the curcumin with great drug loading and encapsulation efficiency. In vitro release study indicates that the curcumin could slowly release from the nanoparticle, which might have great potential application in drug delivery system.
出处 《中国现代应用药学》 CAS CSCD 2012年第6期513-516,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 聚己内酯-聚乙二醇-聚己内酯 姜黄素 体外释放 PCL-PEG-PCL curcumin in vitro release
  • 相关文献

参考文献2

二级参考文献24

  • 1赵同峰,邓华聪,赵江佩.阿魏酸钠对糖尿病大鼠肾脏非酶糖基化和氧化的影响[J].中国病理生理杂志,2004,20(9):1697-1701. 被引量:8
  • 2严世荣,王立林,邱方城.细胞穿膜肽的研究进展[J].生物技术通讯,2006,17(5):796-798. 被引量:6
  • 3沈兴平,李娟,严钟德.肥胖2型糖尿病患者血清E-选择素水平与氧化应激的关系[J].中国病理生理杂志,2006,22(10):2040-2043. 被引量:12
  • 4AARITIM A C, SANDERS R A, WATKINS J B. Diabetes oxidative stress and antioxidants: a review [J]. J Biocherrl Mol Toxico, 2003, 17(1): 24-35.
  • 5SHAMA O P. Antioxidant activity of curcurnin and related compounds [J]. Biochem Phamacol, 1976, 25(15): 1181-1182.
  • 6ZHANGHP XIANGDX LUOJY etal.Research progress in practical pharmacy of solid dispersion technique .中国药学杂志,2007,42(11):807-81.
  • 7HANG WANGCS ZHANGY etal.Study on improvement of curcumin dissolution with solid dispersion .中国中药杂志,2007,32(7):637-638.
  • 8MASUD T, HIDAKA K, SHINOHARA A, et al, Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction from curcumin [J].J Agric Feed Chea, 1999, 47(1): 71-77.
  • 9MAEDA N, TAKEUCHI Y, TAKADA M, et al. Anti-neovascular therapy by use of tumor neovasculature- targeted long-circulating liposome [J]. J Control Release, 2004, 100(1): 41-52.
  • 10KATANASAKAA Y, IDAA T, ASAIA T, et al. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes [J]. Inter J Pharm, 2008, 360(1/2): 219-224.

共引文献14

同被引文献119

引证文献13

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部